Search
Results: 17
CAMPHOR score
Michael Newnham, Katherine Bunclark, Nisha Abraham, Samantha Ali, Liliana Amaral-Almeida, John E Cannon, Natalie Doughty, Choo Ng, Anie Ponnaberanam, Karen Sheares, Nicola Speed, Dolores Taboada, Mark Toshner, Steven Tsui, David P Jenkins, Joanna Pepke-Zaba
May 13, 2020
BACKGROUND: Pulmonary endarterectomy (PEA) is the recommended treatment for eligible patients with chronic thromboembolic pulmonary hypertension (CTEPH). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) score is an...
Cardiovascular Risk Factors Associated With Venous Thromboembolism.
John Gregson, Stephen Kaptoge, Thomas Bolton, Lisa Pennells, Peter Willeit, Stephen Burgess, Steven Bell, Michael Sweeting, Eric B Rimm, Christopher Kabrhel, Bengt Zöller, Gerd Assmann, Vilmundur Gudnason, Aaron R Folsom, Volker Arndt, Astrid Fletcher, Paul E Norman, Børge G Nordestgaard, Akihiko Kitamura, Bakhtawar K Mahmoodi, Peter H Whincup, Matthew Knuiman, Veikko Salomaa, Christa Meisinger, Wolfgang Koenig, Maryam Kavousi, Henry Völzke, Jackie A Cooper, Toshiharu Ninomiya, Edoardo Casiglia, Beatriz Rodriguez, Yoav Ben-Shlomo, Jean-Pierre Després, Leon Simons, Elizabeth Barrett-Connor, Cecilia Björkelund, Marlene Notdurfter, Daan Kromhout, Jackie Price, Susan E Sutherland, Johan Sundström, Jussi Kauhanen, John Gallacher, Joline WJ Beulens, Rachel Dankner, Cyrus Cooper, Simona Giampaoli, Jason F Deen, Agustín Gómez de la Cámara, Lewis H Kuller, Annika Rosengren, Peter J Svensson, Dorothea Nagel, Carlos J Crespo, Hermann Brenner, Juan R Albertorio-Diaz, Robert Atkins, Eric J Brunner, Martin Shipley, Inger Njølstad, Deborah A Lawlor, Yvonne T van der Schouw, Randi Marie Selmer, Maurizio Trevisan, WM Monique Verschuren, Philip Greenland, Sylvia Wassertheil-Smoller, Gordon DO Lowe, Angela M Wood, Adam S Butterworth, Simon G Thompson, John Danesh, Emanuele Di Angelantonio, Tom Meade, Emerging Risk Factors Collaboration
Feb 11, 2019
The outcome of reoperative pulmonary endarterectomy surgery.
Jason M Ali, John Dunning, Choo Ng, Steven Tsui, John E Cannon, Karen K Sheares, Dolores Taboada, Mark Toshner, Nick Screaton, Joanna Pepke-Zaba, David P Jenkins
Sep 26, 2018
OBJECTIVES: Pulmonary endarterectomy (PEA) is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension (PH). Despite excellent outcomes following PEA, a small proportion of patients have residual...
Pulmonary embolism following complex trauma
Thomas E Glover, Joanna E Sumpter, Ari Ercole, Virginia FJ Newcombe, Andrea Lavinio, Andrew D Carrothers, David K Menon, Ronan O'Leary
Aug 19, 2019
OBJECTIVES: To describe the incidence of pulmonary embolism (PE) in a critically ill UK major trauma centre (MTC) patient cohort. METHODS: A retrospective, multidataset descriptive study of all trauma patients requiring...
Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension.
Emilia Maria Swietlik, Alessandro Ruggiero, Andrew J Fletcher, Dolores Taboada, Emily Knightbridge, Louise Harlow, Ian Harvey, Nicholas Screaton, John E Cannon, Karen KK Sheares, Choo Ng, David P Jenkins, Joanna Pepke-Zaba, Mark R Toshner
Dec 10, 2018
There is a current debate surrounding how to classify patients with pulmonary hypertension. The chronic thromboembolic disease is an important area of unmet need with no current treatments. We describe the first prospective...
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy
John E Cannon, Li Su, David G Kiely, Kathleen Page, Mark Toshner, Emilia Swietlik, Carmen Treacy, Anie Ponnaberanam, Robin Condliffe, Karen Sheares, Dolores Taboada, John Dunning, Steven Tsui, Choo Ng, Deepa Gopalan, Nicholas Screaton, Charlie Elliot, Simon Gibbs, Luke Howard, Paul Corris, James Lordan, Martin Johnson, Andrew Peacock, Robert MacKenzie-Ross, Benji Schreiber, Gerry Coghlan, Kostas Dimopoulos, Stephen J Wort, Sean Gaine, Shahin Moledina, David P Jenkins, Joanna Pepke-Zaba
Jun 08, 2018
BACKGROUND: Chronic thromboembolic pulmonary hypertension results from incomplete resolution of pulmonary emboli. Pulmonary endarterectomy (PEA) is potentially curative, but residual pulmonary hypertension following surgery is...
Endarterectomy Hypertension Pulmonary pulmonary embolism survival Adolescent Adult Aged Aged 80 and over Cohort Studies Endarterectomy Female Follow-Up Studies Humans Hypertension Pulmonary Male Middle Aged Prospective Studies Risk Assessment Survival Rate Time Factors Treatment Outcome United Kingdom Young Adult
Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients
Frederick K Ho, Kenneth K C Man, Mark Toshner, Colin Church, Carlos Celis-Morales, Ian C K Wong, Colin Berry, Naveed Sattar, Jill P Pell
Nov 05, 2021
Humans pulmonary embolism Thromboembolism Hospitalization Risk Factors Case-Control Studies Aged Middle Aged Scotland Male covid-19
Published by: Mayo Clinic proceedings
Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021.
Gérald Simonneau, Elie Fadel, Anton Vonk Noordegraaf, Mark Toshner, Irene M Lang, Frederikus A Klok, Micheal C McInnis, Nicholas Screaton, Michael M Madani, Guillermo Martinez, Kiran Salaunkey, David P Jenkins, Hiromi Matsubara, Philippe Brénot, Marius M Hoeper, Hossein A Ghofrani, Xavier Jaïs, Christoph B Wiedenroth, Stefan Guth, Nick H Kim, Joanna Pepke-Zaba, Marion Delcroix, Eckhard Mayer
Mar 13, 2023
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism. It is caused by persistent obstruction of pulmonary arteries by chronic organised fibrotic clots, despite adequate...
Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients
Frederick K Ho, Kenneth KC Man, Mark Toshner, Colin Church, Carlos Celis-Morales, Ian CK Wong, Colin Berry, Naveed Sattar, Jill P Pell
Nov 25, 2021
OBJECTIVE: To assess the associations between coronavirus disease 2019 (COVID-19) infection and thromboembolism including myocardial infarction (MI), ischemic stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)....
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
Michael Newnham, Kieron South, Marta Bleda, William R Auger, Joan A Barberà, Harm Bogaard, Katherine Bunclark, John E Cannon, Marion Delcroix, Charaka Hadinnapola, Luke S Howard, David Jenkins, Eckhard Mayer, Choo Ng, Christopher J Rhodes, Nicholas Screaton, Karen Sheares, Michael A Simpson, Mark Southwood, Li Su, Dolores Taboada, Matthew Traylor, Richard C Trembath, Sofia S Villar, Martin R Wilkins, John Wharton, Stefan Gräf, Joanna Pepke-Zaba, Michael Laffan, David A Lane, Nicholas W Morrell, Mark Toshner
Jan 31, 2019
Chronic thromboembolic pulmonary hypertension (CTEPH) is an important consequence of pulmonary embolism that is associated with abnormalities in haemostasis. We investigated the ADAMTS13-von Willebrand factor (VWF) axis in...
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases
Rochelle Knight, Venexia Walker, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Rachel Denholm, Ashley Akbari, Hoda Abbasizanjani, Fatemeh Torabi, Efosa Omigie, Sam Hollings, Teri-Louise North, Renin Toms, Xiyun Jiang, Emanuele Di Angelantonio, Spiros Denaxas, Johan H Thygesen, Christopher Tomlinson, Ben Bray, Craig J Smith, Mark Barber, Kamlesh Khunti, George Davey Smith, Nishi Chaturvedi, Cathie Sudlow, William N Whiteley, Angela M Wood, Jonathan AC Sterne, CVD-COVID-UK/COVID-IMPACT Consortium and the Longitudinal Health and Wellbeing COVID-19 National Core Study
Oct 24, 2022
Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection.
Stavros I Tyritzis, Anna Wallerstedt, Gunnar Steineck, Tommy Nyberg, Jonas Hugosson, Anders Bjartell, Ulrica Wilderäng, Thordis Thorsteinsdottir, Stefan Carlsson, Johan Stranne, Eva Haglind, Nils Peter Wiklund, LAPPRO Steering Committee
Jun 15, 2018
PURPOSE: Lymph node dissection in patients with prostate cancer may increase complications. An association of lymph node dissection with thromboembolic events was suggested. We compared the incidence and investigated predictors...
Ventriculo-arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease.
Richard G Axell, Simon J Messer, Paul A White, Colm McCabe, Andrew Priest, Thaleia Statopoulou, Maja Drozdzynska, Jamie Viscasillas, Elizabeth C Hinchy, James Hampton-Till, Hatim I Alibhai, Nicholas Morrell, Joanna Pepke-Zaba, Stephen R Large, Stephen P Hoole
Jun 20, 2018
Chronic thromboembolic disease (CTED) is suboptimally defined by a mean pulmonary artery pressure (mPAP) <25 mmHg at rest in patients that remain symptomatic from chronic pulmonary artery thrombi. To improve identification of...
Chronic thromboembolic disease Chronic thromboembolic pulmonary hypertension right ventricular dysfunction ventriculo‐arterial coupling Adult Aged Animals Chronic Disease Female Humans Hypertension Pulmonary Male Middle Aged Pulmonary Circulation pulmonary embolism Swine Ventricular Dysfunction Right
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Stephen P Hoole, John G Coghlan, John E Cannon, Dolores Taboada, Mark Toshner, Karen Sheares, Andrew John Fletcher, Guillermo Martinez, Alessandro Ruggiero, Nicholas Screaton, David Jenkins, Joanna Pepke-Zaba
May 06, 2020
OBJECTIVE: Inoperable chronic thromboembolic pulmonary hypertension (CTEPH) managed medically has a poor prognosis. Balloon pulmonary angioplasty (BPA) offers a new treatment for inoperable patients. The national BPA service for...
Balloon pulmonary angioplasty Chronic thromboembolic pulmonary hypertension Right heart function Aged Angioplasty Balloon Arterial Pressure Chronic Disease Exercise Tolerance Female Humans Hypertension Pulmonary Male Middle Aged Pulmonary Artery pulmonary embolism Recovery of Function Time Factors Treatment Outcome United Kingdom Vascular Resistance Ventricular Function Right Ventricular Remodeling
Pulmonary thromboembolic events in COVID-19 - a systematic literature review.
Paul M Overton, Mark Toshner, Claire Mulligan, Pareen Vora, Sylvia Nikkho, Jan de Backer, Ben R Lavon, Frederikus A Klok
Sep 09, 2022
Pulmonary thromboembolic events (TE) have been linked to coronavirus disease 2019 (COVID-19), but their incidence and long-term sequelae remain unclear. We performed a systematic literature review to investigate the incidence of...
Published by: Pulmonary circulation